Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy

다국어 초록 (Multilingual Abstract)

Purpose: We evaluated the characteristics of patients with Kawasaki disease (KD) who presented with only fever and cervical lymphadenopathy on admission, and compared them with the characteristics of those who presented with typical features but no cervical lymphadenopathy.
Methods: We enrolled 98 patients diagnosed with KD. Thirteen patients had only fever and cervical lymphadenopathy on the day of admission (group 1), 31 had typical features with cervical lymphadenopathy (group 2), and 54 had typical features without cervical lymphadenopathy (group 3).
Results: The mean age (4.3±2.1 years) and duration of fever (7.5±3.6 days) before the first intravenous immunoglobulin (IVIG) administration were highest in group 1 (P=0.001). Moreover, this group showed higher white blood cell and neutrophil counts, and lower lymphocyte counts after the first IVIG administration as compared to the other groups (P=0.001, P=0.001, and P=0.003, respectively). Group 1 also had a longer duration of hospitalization and higher frequency of second-line treatment as compared to groups 2 and 3 (group 1 vs. group 2, P=0.000 and P=0.024; group 1 vs. group 3, P=0.000 and P=0.007). A coronary artery z score of >2.5 was frequently observed in group 1 than in group 3 (P= 0.008).
Conclusion: KD should be suspected in children who are unresponsive to antibiotics and have prolonged fever and cervical lymphadenopathy, which indicates that KD is associated with the likelihood of requiring second-line treatment and risk of developing coronary artery dilatation.

참고문헌 (Reference)

1 Meissner HC, "Superantigens, conventional antigens and the etiology of Kawasaki syndrome" 19 : 91-94, 2000

2 Fan PC, "School-aged children with Kawasaki disease : high incidence of cervical lymphadenopathy and coronary artery involvement" 39 : 55-57, 2003

3 Egami K, "Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease" 149 : 237-240, 2006

4 Kobayashi T, "Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease" 113 : 2606-2612, 2006

5 Dallaire F, "New equations and a critical appraisal of coronary artery Z scores in healthy children" 24 : 60-74, 2011

6 Kanegaye JT, "Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease" 162 : 1259-1263, 2013

7 Sung RY, "Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease" 25 : 521-525, 2006

8 Wang CL, "Kawasaki disease:infection, immunity and genetics" 24 : 998-1004, 2005

9 Kubota M, "Kawasaki disease with lymphadenopathy and fever as sole initial manifestations" 44 : 359-362, 2008

10 Burns JC, "Kawasaki disease update" 76 : 71-76, 2009

11 김동수, "Kawasaki Disease" 연세대학교의과대학 47 (47): 759-772, 2006

12 Ghelani SJ, "Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines" 33 : 1097-1103, 2012

13 Leahy TR, "Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: a case report" 23 : 137-139, 2012

14 Tashiro N, "Furukawa S. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease" 109 : E77-E87, 2002

15 Lee KY, "Features of Kawasaki disease at the extremes of age" 42 : 423-427, 2006

16 Meier JD, "Evaluation and management of neck masses in children" 89 : 353-358, 2014

17 Kim GB, "Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011" 33 : 24-27, 2011

18 Yanagi S, "Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy" 50 : 179-183, 2008

19 Baek HJ, "Diagnostic accuracy of the clinical and CT findings for differentiating Kikuchi's disease and tuberculous lymphadenitis presenting with cervical lymphadenopathy" 32 : 637-643, 2014

20 Newburger JW, "Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association" 114 : 1708-1733, 2004

21 Burns JC, "Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group" 118 : 680-686, 1991

22 노경민, "CT Analysis of Retropharyngeal Abnormality in Kawasaki Disease" 대한영상의학회 12 (12): 700-707, 2011

23 Nomura Y, "A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission" 156 : 786-791, 2010

24 최세현, "A case of Kawasaki disease with coexistence of a parapharyngeal abscess requiring incision and drainage" 대한소아과학회 53 (53): 855-858, 2010